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Variables Mean  SD, or No. (%)
Crossing knee joint 24/26 (92)
Stents, No. 1.8  1.1
Distal runoff vessels, No. 1.96  0.75
Length of stay, days 2.4  2.4
Follow-up, mon 22  17
AAA, Abdominal aortic aneurysm.
Results: There was one technical failure due to stent graft infolding,
requiring conversion to an open femoral-popliteal bypass. One patient was
lost to follow-up. Primary and secondary patency rates were, respectively,
95% and 95% at 1 year and 87% and 92% at 2 years. The limb salvage rate was
100%. Three graft failures occurred at a mean of 14.6 11months. All graft
failures occurred in patients with poor (single-vessel) run-off. The presence
of symptoms did not significantly affect graft patency rates (P  NS).
Compared with patients with two- or three-vessel run-off, the graft failure
rate in patients with single-vessel run-off was statistically significant (P 
.02). Two of the graft failures were successfully treated with open throm-
bectomy and one required a tibial artery bypass for limb salvage. Mean
follow-up was 22  17 months (range, 1-57 months).
Conclusions: Endovascular repair of PAAs with the Viabahn® endo-
prosthesis is feasible and has acceptable midterm patency rates. Poor distal
runoff may predict graft failure.
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Objective(s):Duplex velocity criteria (DVC) to identify in-stent celiac
artery (CA) and superior mesenteric artery (SMA) stenosis are not well-
defined. Only one study has been published, which concluded that DVC for
native SMA stenosis overestimated stenosis in stented SMAs. This study
analyzed DVC in detecting CA/SMA in-stent stenosis (ISS).
Methods: Sixty-two stents (32 SMA and 30 CA) that had concurrent
postoperative duplex ultrasound images and angiograms for significant ISS
by DVC were analyzed. A receiver operator characteristic curve (ROC)
analysis was used to determine optimal DVC, defined as peak systolic
velocities (PSV), end-diastolic velocities (EDV), and systolic ratios, for
2
3etecting50% and70% ISS. These were compared with duplex velocities
btained from 97 native CAs and 74 native SMAs with50% stenosis done
n the same study period.
Results:Themean stented celiac PSV (c/s), EDV, and systolic ratio for
50% ISS were, respectively, 447, 136, and 7.1 vs 379, 104, and 5.2 for
50% native stenosis (P .067, P .106, P .01). Themean stented SMA
SV, EDV, and ratio for 50% ISS were 410, 114, and 6.2 vs 405, 76, and
.0 for50% native stenosis (P .885, P.037, P .0001). The PSV cut
oints for detecting50% SMA ISS was 325 c/s (sensitivity 88%, specificity
00%, and overall accuracy 91%) vs 295 c/s for 50% native SMA and for
70% SMA ISS was 412 (sensitivity 100%, specificity 95%, and overall
ccuracy 97%) vs 400 for native stenosis. The PSV cut points for 50% CA
SS was 274 c/s (sensitivity 96%, specificity 86%, overall accuracy 93%) vs
40 c/s for50% native stenosis, and for70% CA ISS was 363 (sensitivity
8%, specificity 92%, and overall accuracy 90%). ROC analysis also showed
hat both PSVs and EDVs were equal predictors for SMA and CA50% and
70% ISS. For 50% SMA ISS, the area under the curve (AUC) for PSV
quals 0.91 and EDV equals 0.81 (P .341). For CA the PSV, AUC equals
.99 and EDV equals 0.88 (P  .063; Fig).
Conclusions: There is a tendency toward higher velocities in stented
A/SMAs compared with native arteries. Caution must be exercised in
sing DVC of native CA/SMA stenosis for stented CA/SMA. Further
rospective validation studies are needed.
ffective Treatment of Femoropopliteal In-Stent Restenosis With
tent Grafts
homas S. Monahan, MD, Shant Vartanian, MD, Darren B. Schneider,
D, University of Maryland, Baltimore, Md
Objective(s): Restenosis remains a significant clinical problem after
emoropopliteal intervention, and the primary cause of failure after femoro-
opliteal stent placement is in-stent restenosis (ISR). Although angioplasty
s commonly used to treat ISR, it is ineffective, with reported recurrence
ates of up to 60%within 6months.We hypothesized that relining with stent
rafts, which provide a barrier against neointimal hyperplasia, would provide
more effective treatment of ISR.
Methods:We reviewed our experience using relining with stent grafts
o treat femoropopliteal ISR in 24 limbs in 22 patients between 2006 and
010. Patients presented with recurrent symptoms or with hemodynami-
ally significant ISR identified by surveillance ultrasound imaging. ISR was
reated by complete relining of previously placed stents with one or more
iabahn® stent grafts (W.L. Gore & Associates, Flagstaff, Ariz). Objective
atency was determined by duplex ultrasound imaging and clinical outcome
ata was obtained from review of patient records.
Results: The median time from primary stent placement to reinterven-
ion for ISR was 201 days (interquartile range, 139-521 days). Of 24 limbs,
1 were treated for ISR within stents in native femoropopliteal arteries and
were treated for ISR within stents in femoropopliteal bypass grafts. Most
